SCHEMBL485349

SCHEMBL485349

CC(C)(C)OC(=O)NC1CCc2ccc(Br)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.43
AAK1 Q2M2I8 3/20 0.42
ACHE P22303 2/20 0.39
GAA P10253 1/20 0.39
USP30 Q70CQ3 1/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
EPHX2 P34913 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485350 1.00 BACE1 (0.43) BACE1AAK1ACHEGAAUSP30
SCHEMBL21178364 0.90 TRPV1 (0.46) BACE1AAK1GAAUSP30NPC1
SCHEMBL31055885 0.90 TRPV1 (0.46) BACE1AAK1GAAUSP30NPC1
SCHEMBL5269808 0.90 TRPV1 (0.46) BACE1AAK1GAAUSP30NPC1
SCHEMBL29652278 0.90 TRPV1 (0.46) BACE1AAK1GAAUSP30NPC1
SCHEMBL8180722 0.90 TRPV1 (0.46) BACE1AAK1GAAUSP30NPC1
SCHEMBL3300984 0.86 MAOA (0.50) ACHEGAAEPHX2NFKB1NFKB2
SCHEMBL17040762 0.86 TRPV1 (0.46) ACHEGAAEPHX2LMNAKMT2A
SCHEMBL7942829 0.86 MAOA (0.50) ACHEGAAEPHX2NFKB1NFKB2
SCHEMBL1372805 0.86 MAOA (0.50) ACHEGAAEPHX2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12454525-B2 IL4I1 inhibitors and methods of use MERCK SHARP & DOHME LLC (US) 2025-10-28 US disclosed
US-20230183214-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC 2023-06-15 US disclosed
EP-4146644-A1 IL4I1 INHIBITORS AND METHODS OF USE Merck Sharp & Dohme LLC (US) 2023-03-15 EP disclosed
CN-108137509-B Pyrrole, oxadiazole, triazole or tetrazole derivatives suitable for controlling arthropods 拜耳作物科学股份公司 2021-03-19 CN disclosed
EP-3334711-B1 DERIVATIVES OF PYRROLE, DIAZOLE, TRIAZOLE OR TETRAZOLE FOR COMBATING ARTHROPODS BAYER CROPSCIENCE AG (DE) 2020-09-23 EP disclosed
US-10357036-B2 Compounds for controlling arthropods BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-07-23 US disclosed
US-20180289007-A1 NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-10-11 US disclosed
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-06-19 US disclosed
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-06-19 US disclosed
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-07-06 US disclosed
US-9556197-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2017-01-31 US disclosed
CN-105658653-A Furo- and thieno-pyridine carboxamide compounds useful as PIM kinase inhibitors 因赛特公司 2016-06-08 CN disclosed
WO-2015027124-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION (US) 2015-02-26 WO disclosed
US-20150057265-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION (US) 2015-02-26 US disclosed
US-20150057265-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION (US) 2015-02-26 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 BACE1 4368/4885AAK1 297/4885ACHE 4533/4885
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN BACE1 2037/4885AAK1 1392/4885ACHE 3999/4885
US-20230183214-A1 IL4I1 INHIBITORS AND METHODS OF USE IL4I1, IL4, IL2 BACE1 3841/4885AAK1 1349/4885ACHE 4859/4885
US-10357036-B2 Compounds for controlling arthropods DDT, ACHE, NISCH BACE1 2873/4885AAK1 1189/4885ACHE 2/4885
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors PIM1, PIM2, PIM3 BACE1 4368/4885AAK1 297/4885ACHE 4533/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN BACE1 2037/4885AAK1 1392/4885ACHE 3999/4885
US-12454525-B2 IL4I1 inhibitors and methods of use IL4I1, IL4, IL2 BACE1 3841/4885AAK1 1349/4885ACHE 4859/4885
US-20180289007-A1 NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS DDT, ACHE, NISCH BACE1 2578/4885AAK1 941/4885ACHE 2/4885
US-20150057265-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 BACE1 4368/4885AAK1 297/4885ACHE 4533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.